Resultados de la búsqueda 11-20 of 235 for ���������������������������Talk:PC53������������������ ������

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phone teleconference. We will survey patients at baseline and then at pre-specified timepoints up to 2 years after CAR-T. Survey questionnaires that have ...

4. Mayo Clinic Otolaryngology Physician Update - December 2024

   Page 1.

5. Mayo Clinic Otolaryngology Physician Update - October 2024

   Page 1.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

7. Salud del adulto Noticias de la Mayo Clinic

   Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad y experiencia en el control de ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... phone teleconference. We will survey patients at baseline and then at pre-specified timepoints up to 2 years after CAR-T. Survey questionnaires that have ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phone teleconference. We will survey patients at baseline and then at pre-specified timepoints up to 2 years after CAR-T. Survey questionnaires that have ...